Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1775 of 2406 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/01/17
End: 08/01/37
Due: 08/01/38
Phase: N/A
Priority: Normal
Start: 08/14/20
End: 07/31/23
Due: 07/31/24
Phase: N/A
Priority: Normal
Start: 08/01/16
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 08/31/08
Due: 08/31/09
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 11/01/18
End: 12/28/18
Due: 12/28/19
Phase: N/A
Priority: Normal
Start: 03/18/19
End: 05/18/19
Due: 05/18/20
Phase: N/A
Priority: Normal
Start: 01/31/02
End: 05/31/05
Due: 05/31/06
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 05/01/18
End: 06/27/18
Due: 06/27/19
Phase: N/A
Priority: Normal
Start: 11/30/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 03/25/24
End: 05/05/24
Due: 05/05/25
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 11/30/16
Due: 11/30/17
Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
Phase: N/A
Priority: Normal
Start: 10/31/04
End: 12/31/06
Due: 12/31/07
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 07/01/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 07/31/22
Due: 07/31/23
Phase: N/A
Priority: Normal
Start: 07/24/20
End: 03/31/23
Due: 03/31/24
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 12/31/15
Due: 12/31/16